Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg ethinyl estradiol and 75 μg gestodene
- 31 August 2001
- journal article
- Published by Elsevier in Contraception
- Vol. 64 (2) , 99-105
- https://doi.org/10.1016/s0010-7824(01)00232-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrelContraception, 2000
- Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyContraception, 1999
- Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranovar`) in GermanyThe European Journal of Contraception & Reproductive Health Care, 1999
- A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cyclesContraception, 1997
- Shorter pill-free interval in combined oral contraceptives decreases follicular developmentContraception, 1996
- A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodeneGynecological Endocrinology, 1996
- Oral contraceptives and cycle control: A critical review of the literatureAdvances in Contraception, 1992